| Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients A Zehir, R Benayed, RH Shah, A Syed, S Middha, HR Kim, P Srinivasan, ... Nature medicine 23 (6), 703-713, 2017 | 3257 | 2017 |
| Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): a hybridization capture-based next-generation sequencing clinical assay for … DT Cheng, TN Mitchell, A Zehir, RH Shah, R Benayed, A Syed, ... The Journal of molecular diagnostics 17 (3), 251-264, 2015 | 1972 | 2015 |
| Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers I Landa, T Ibrahimpasic, L Boucai, R Sinha, JA Knauf, RH Shah, S Dogan, ... The Journal of clinical investigation 126 (3), 1052-1066, 2016 | 1175 | 2016 |
| Convergent loss of PTEN leads to clinical resistance to a PI (3) Kα inhibitor D Juric, P Castel, M Griffith, OL Griffith, HH Won, H Ellis, SH Ebbesen, ... Nature 518 (7538), 240-244, 2015 | 610 | 2015 |
| Tracking tumour evolution in glioma through liquid biopsies of cerebrospinal fluid AM Miller, RH Shah, EI Pentsova, M Pourmaleki, S Briggs, N Distefano, ... Nature 565 (7741), 654-658, 2019 | 533 | 2019 |
| Mutation detection in patients with advanced cancer by universal sequencing of cancer-related genes in tumor and normal DNA vs guideline-based germline testing D Mandelker, L Zhang, Y Kemel, ZK Stadler, V Joseph, A Zehir, ... Jama 318 (9), 825-835, 2017 | 506 | 2017 |
| Comparative sequencing analysis reveals high genomic concordance between matched primary and metastatic colorectal cancer lesions AR Brannon, E Vakiani, BE Sylvester, SN Scott, G McDermott, RH Shah, ... Genome biology 15, 1-10, 2014 | 387 | 2014 |
| Recurrent SMARCA4 mutations in small cell carcinoma of the ovary P Jelinic, JJ Mueller, N Olvera, F Dao, SN Scott, R Shah, JJ Gao, ... Nature Genetics, 2014 | 383 | 2014 |
| Evaluating cancer of the central nervous system through next-generation sequencing of cerebrospinal fluid EI Pentsova, RH Shah, J Tang, A Boire, D You, S Briggs, A Omuro, X Lin, ... Journal of clinical oncology 34 (20), 2404-2415, 2016 | 381 | 2016 |
| Genomic characterization of upper tract urothelial carcinoma JP Sfakianos, EK Cha, G Iyer, SN Scott, EC Zabor, RH Shah, Q Ren, ... European urology 68 (6), 970-977, 2015 | 254 | 2015 |
| Alternative transcription initiation leads to expression of a novel ALK isoform in cancer T Wiesner, W Lee, AC Obenauf, L Ran, R Murali, QF Zhang, EWP Wong, ... Nature 526 (7573), 453-457, 2015 | 251 | 2015 |
| Genomic predictors of survival in patients with high-grade urothelial carcinoma of the bladder PH Kim, EK Cha, JP Sfakianos, G Iyer, EC Zabor, SN Scott, I Ostrovnaya, ... European urology 67 (2), 198-201, 2015 | 168 | 2015 |
| Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative … CJ Tsai, JT Yang, N Shaverdian, J Patel, AF Shepherd, J Eng, ... The Lancet 403 (10422), 171-182, 2024 | 118 | 2024 |
| The oncocytic subtype is genetically distinct from other pancreatic intraductal papillary mucinous neoplasm subtypes O Basturk, M Tan, U Bhanot, P Allen, V Adsay, SN Scott, R Shah, ... Modern Pathology 29 (9), 1058-1069, 2016 | 107 | 2016 |
| Detecting somatic genetic alterations in tumor specimens by exon capture and massively parallel sequencing HH Won, SN Scott, AR Brannon, RH Shah, MF Berger Journal of visualized experiments: JoVE, 50710, 2013 | 78 | 2013 |
| Novel insights into breast cancer copy number genetic heterogeneity revealed by single-cell genome sequencing T Baslan, J Kendall, K Volyanskyy, K McNamara, H Cox, S D'Italia, ... elife 9, e51480, 2020 | 73 | 2020 |
| Real-time genomic characterization of metastatic pancreatic neuroendocrine tumors has prognostic implications and identifies potential germline actionability N Raj, R Shah, Z Stadler, S Mukherjee, J Chou, B Untch, J Li, V Kelly, ... JCO precision oncology 2, 1-18, 2018 | 72 | 2018 |
| Sequencing of 279 cancer genes in ampullary carcinoma reveals trends relating to histologic subtypes and frequent amplification and overexpression of ERBB2 (HER2) JF Hechtman, W Liu, J Sadowska, L Zhen, L Borsu, ME Arcila, HH Won, ... Modern Pathology 28 (8), 1123-1129, 2015 | 70 | 2015 |
| Clinical and genetic determinants of ovarian metastases from colorectal cancer K Ganesh, RH Shah, E Vakiani, GM Nash, HP Skottowe, R Yaeger, ... Cancer 123 (7), 1134-1143, 2017 | 64 | 2017 |
| Antitumour activity of neratinib in patients with HER2-mutant advanced biliary tract cancers JJ Harding, SA Piha-Paul, RH Shah, JJ Murphy, JM Cleary, GI Shapiro, ... Nature communications 14 (1), 630, 2023 | 49 | 2023 |
Michael F BergerMember, Memorial Sloan-Kettering Cancer CenterAdresse e-mail validée de mskcc.org